Korean Journal of Radiology

  • 제19권5호
  • /
  • Pages.923-929
  • /
  • 2018
  • /
  • 1229-6929(pISSN)
  • /
  • 2005-8330(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지
DOI QR코드

DOI QR Code

Correlation between Non-Alcoholic Fatty Liver Disease and Visceral Adipose Tissue in Non-Obese Chinese Adults: A CT Evaluation

  • Yu, Ai-Hong (Department of Radiology, Beijing Jishuitan Hospital, the 4th Medical College of Peking University) ;
  • Duan-Mu, Yang-Yang (Department of Radiology, First Affiliated Hospital of Anhui Medical University) ;
  • Zhang, Yong (Department of Radiology, Beijing Jishuitan Hospital, the 4th Medical College of Peking University) ;
  • Wang, Ling (Department of Radiology, Beijing Jishuitan Hospital, the 4th Medical College of Peking University) ;
  • Guo, Zhe (Department of Radiology, Beijing Jishuitan Hospital, the 4th Medical College of Peking University) ;
  • Yu, Yong-Qiang (Department of Radiology, First Affiliated Hospital of Anhui Medical University) ;
  • Wang, Yu-Sheng (Department of Radiology, Beijing Jishuitan Hospital, the 4th Medical College of Peking University) ;
  • Cheng, Xiao-Guang (Department of Radiology, Beijing Jishuitan Hospital, the 4th Medical College of Peking University)
  • 투고 : 2017.07.27
  • 심사 : 2018.02.17
  • 발행 : 2018.10.01
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: To investigate the correlation between non-alcoholic fatty liver disease and visceral adipose tissue in non-obese Chinese adults using computed tomography (CT). Materials and Methods: The study included 454 subjects undergoing abdominal CT scan. Degree of CT attenuation in liver and spleen, and the degree of fat infiltration in liver were evaluated according to three indices: the attenuation value of liver parenchyma ($CT_{LP}$), the attenuation ratio of liver and spleen ($LS_{ratio}$) and the attenuation difference between liver and spleen ($LS_{dif}$). Visceral fat area (VFA) and total fat area (TFA) at L2/3 and L4/5 levels were measured, and the abdominal subcutaneous fat area (SFA) was calculated. Bivariate correlation analysis was carried out to determine the correlation among these factors. Results: In men, VFA, SFA and TFA at L2/3 and L4/5 levels showed significant differences in terms of the three indices to distinguish fatty liver from non-fatty liver (all, p < 0.001). In men, all the three indices showed negative correlation with TFA, SFA and VFA (all, p < 0.001). The negative correlation between the three indices and VFA at the L2/3 level was higher than at L4/5 level (r = -0.476 vs. r = -0.340 for $CT_{LP}$, r = -0.502 vs. r = -0.413 for $LS_{ratio}$, r = -0.543 vs. r = -0.422 for $LS_{dif}$, p < 0.001, respectively). The negative correlation between $LS_{ratio}$, $LS_{dif}$ and VFA at L2/3 and L4/5 levels was higher than SFA at the corresponding level. In women, all the three indices showed negative correlation with VFA and TFA at L2/3 and L4/5 levels, and the negative correlation between $CT_{LP}$ and VFA was higher at L2/3 level than at L4/5 level (r = -0.294 vs. r = -0.254, p < 0.001). Conclusion: In non-obese Chinese adults, the degree of hepatic fatty infiltration showed a strong correlation with abdominal fat on CT. VFA at L2/3 level was more closely related to fatty liver compared with VFA at L4/5 level.

키워드

참고문헌

  1. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ 2005;172:899-905 https://doi.org/10.1503/cmaj.045232
  2. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34:274-285 https://doi.org/10.1111/j.1365-2036.2011.04724.x
  3. Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43:617-649 https://doi.org/10.3109/07853890.2010.518623
  4. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005;143:722-728 https://doi.org/10.7326/0003-4819-143-10-200511150-00009
  5. Kwon YM, Oh SW, Hwang SS, Lee C, Kwon H, Chung GE. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am J Gastroenterol 2012;107:1852-1858 https://doi.org/10.1038/ajg.2012.314
  6. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48 https://doi.org/10.1161/CIRCULATIONAHA.106.675355
  7. Sogabe M, Okahisa T, Tsujigami K, Fukuno H, Hibino S, Yamanoi A. Visceral fat predominance is associated with non-alcoholic fatty liver disease in Japanese women with metabolic syndrome. Hepatol Res 2014;44:515-522 https://doi.org/10.1111/hepr.12146
  8. Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol 2006;40:745-752 https://doi.org/10.1097/00004836-200609000-00016
  9. Das K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology 2010;51:1593-1602 https://doi.org/10.1002/hep.23567
  10. Xu C, Yu C, Ma H, Xu L, Miao M, Li Y. Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study. Am J Gastroenterol 2013;108:1299-1304 https://doi.org/10.1038/ajg.2013.104
  11. Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW, et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 2004;230:276-280 https://doi.org/10.1148/radiol.2301021176
  12. Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Liver Disease Association. [Diagnostic criteria of nonalcoholic fatty liver disease]. Zhonghua Gan Zang Bing Za Zhi 2003;11:71
  13. Yajima Y, Narui T, Ishii M, Abe R, Ohtsuki M, Goto Y, et al. Computed tomography in the diagnosis of fatty liver: total lipid content and computed tomography number. Tohoku J Exp Med 1982;136:337-342 https://doi.org/10.1620/tjem.136.337
  14. Wang L, Wang W, Deng W, Jiang F, Xu J, Zhao H, et al. [The reproducibility of abdominal fat area and distribution measured by QCT]. Chinese Journal of Osteoporosis 2012;11:999-1003
  15. Ha Y, Seo N, Shim JH, Kim SY, Park JA, Han S, et al. Intimate association of visceral obesity with non-alcoholic fatty liver disease in healthy Asians: a case-control study. J Gastroenterol Hepatol 2015;30:1666-1672 https://doi.org/10.1111/jgh.12996
  16. Lee JY, Kim KM, Lee SG, Yu E, Lim YS, Lee HC, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 2007;47:239-244 https://doi.org/10.1016/j.jhep.2007.02.007
  17. Omagari K, Kadokawa Y, Masuda J, Egawa I, Sawa T, Hazama H, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol 2002;17:1098-1105 https://doi.org/10.1046/j.1440-1746.2002.02846.x
  18. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:697-738 https://doi.org/10.1210/edrv.21.6.0415
  19. Lear SA, Humphries KH, Kohli S, Birmingham CL. The use of BMI and waist circumference as surrogates of body fat differs by ethnicity. Obesity (Silver Spring) 2007;15:2817-2824 https://doi.org/10.1038/oby.2007.334
  20. Oliva MR, Mortele KJ, Segatto E, Glickman JN, Erturk SM, Ros PR, et al. Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation. J Comput Assist Tomogr 2006;30:37-43 https://doi.org/10.1097/01.rct.0000193818.31749.84
  21. Xie S, Li Q, Cheng Y, Zhang Y, Zhuo Z, Zhao G, et al. Impact of liver fibrosis and fatty liver on T1rho measurements: a prospective study. Korean J Radiol 2017;18:898-905 https://doi.org/10.3348/kjr.2017.18.6.898
  22. Yoo H, Lee JM, Yoon JH, Kang HJ, Lee SM, Yang HK, et al. T2* mapping from multi-echo dixon sequence on gadoxetic acid-enhanced magnetic resonance imaging for the hepatic fat quantification: can it be used for hepatic function assessment? Korean J Radiol 2017;18:682-690 https://doi.org/10.3348/kjr.2017.18.4.682
  23. Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003;15:539-543
  24. Kuk JL, Church TS, Blair SN, Ross R. Does measurement site for visceral and abdominal subcutaneous adipose tissue alter associations with the metabolic syndrome? Diabetes Care 2006;29:679-684 https://doi.org/10.2337/diacare.29.03.06.dc05-1500
  25. Jakobsen MU, Berentzen T, Sorensen TI, Overvad K. Abdominal obesity and fatty liver. Epidemiol Rev 2007;29:77-87 https://doi.org/10.1093/epirev/mxm002
  26. Kobayashi J, Tadokoro N, Watanabe M, Shinomiya M. A novel method of measuring intra-abdominal fat volume using helical computed tomography. Int J Obes Relat Metab Disord 2002;26:398-402 https://doi.org/10.1038/sj.ijo.0801921
  27. Demerath EW, Sun SS, Rogers N, Lee M, Reed D, Choh AC, et al. Anatomical patterning of visceral adipose tissue: race, sex, and age variation. Obesity (Silver Spring) 2007;15:2984-2993 https://doi.org/10.1038/oby.2007.356
  28. Han TS, Kelly IE, Walsh K, Greene RM, Lean ME. Relationship between volumes and areas from single transverse scans of intra-abdominal fat measured by magnetic resonance imaging. Int J Obes Relat Metab Disord 1997;21:1161-1166 https://doi.org/10.1038/sj.ijo.0800530
  29. Demerath EW, Shen W, Lee M, Choh AC, Czerwinski SA, Siervogel RM, et al. Approximation of total visceral adipose tissue with a single magnetic resonance image. Am J Clin Nutr 2007;85:362-368 https://doi.org/10.1093/ajcn/85.2.362
  30. Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, et al. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 2002;87:5662-5667 https://doi.org/10.1210/jc.2002-020635

피인용 문헌

  1. Fatty Liver Has Stronger Association With Insulin Resistance Than Visceral Fat Accumulation in Nonobese Japanese Men vol.3, pp.7, 2018, https://doi.org/10.1210/js.2019-00052
  2. Impact of Androgen Deprivation Therapy on Non-Alcoholic Fatty Liver Disease in Patients with Prostate Cancer: A CT Evaluation vol.104, pp.5, 2018, https://doi.org/10.1159/000507351
  3. Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy vol.9, pp.1, 2020, https://doi.org/10.3390/jcm9010015
  4. Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease vol.26, pp.42, 2018, https://doi.org/10.3748/wjg.v26.i42.6658
  5. Fasting, Nutrition and Weight Loss: An Approach to Refine Non-Alcoholic Fatty Liver Disease vol.67, pp.6, 2018, https://doi.org/10.3177/jnsv.67.366
  6. Association between Visceral Adipose Tissue and Non-Alcoholic Steatohepatitis Histology in Patients with Known or Suspected Non-Alcoholic Fatty Liver Disease vol.10, pp.12, 2021, https://doi.org/10.3390/jcm10122565
  7. Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver vol.11, pp.6, 2018, https://doi.org/10.3390/diagnostics11061061
  8. Visceral adiposity as a risk factor for lean non‐alcoholic fatty liver disease in potential living liver donors vol.36, pp.11, 2018, https://doi.org/10.1111/jgh.15597